I agree with your train of thought but did more then hold my shares ... After running I came back and made a couple purchases. I agree with your earlier post on valuation and though I probably think a buyout is less likely then you I think the "value" in the company is significantly higher and think their FOB program is worth a fair amount and is increasing in value... Plus I heard Wheeler's last presentation again (while Running) and think a Teva approval could come later rather then sooner and the market has priced in as very soon.